Mark Griffey

Engineers Sharpen Gene-Editing Tools To Target Cystic Fibrosis

Engineered A3G base editors reduce unintended “bystander” edits, yielding safer potential treatments for cystic fibrosis and more accurate models for drug testing.

Read More